Margaret Keegan

Money Moves

As of August 2026: Will lead Precision into McKesson's Oncology & Multispecialty segment

The largest US drug distributor, McKesson, agreed on August 25 to buy Precision Medicine Group for $2.25 billion. Precision runs clinical trials, biomarker labs, and payer-negotiation services for biotechnology and pharmaceutical companies.

Updated Aug 26